Article Figures & Tables
Tables
In this issue
Article tools
Respond to this article
Direct oral anticoagulants and the bleeding patient
Jump to section
- Article
- Direct oral anticoagulant agents are now routinely used for the prevention of stroke in nonvalvular atrial fibrillation
- Risk of bleeding with direct oral anticoagulants is lower than with vitamin K antagonists, but varies by site
- Direct oral anticoagulants are characterized by rapid onset of action and short half-lives2
- Direct oral anticoagulants variably affect standard clot-based assays
- Idarucizumab has recently been approved by the US Food and Drug Administration to reverse the activity of dabigatran
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics
Related Articles
Cited By...
- No citing articles found.